Targeting neuroinflammation in neuropathic pain and opioid use

por Salvemini, Daniela, Doyle, Timothy M.
Publicado 2022

Adenosine A(3) receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury

por Farr, Susan A., Cuzzocrea, Salvatore, Esposito, Emanuela, Campolo, Michela, Niehoff, Michael L., Doyle, Timothy M., Salvemini, Daniela
Publicado 2020

Sphingosine-1-phosphate receptor subtype 1 activation in the central nervous system contributes to morphine withdrawal in rodents

por Doyle, Timothy M., Hutchinson, Mark R., Braden, Kathryn, Janes, Kali, Staikopoulos, Vicky, Chen, Zhoumou, Neumann, William L., Spiegel, Sarah, Salvemini, Daniela
Publicado 2020

Sphingosine-1-phosphate receptor 1 activation in the central nervous system drives cisplatin-induced cognitive impairment

por Squillace, Silvia, Niehoff, Michael L., Doyle, Timothy M., Green, Michael, Esposito, Emanuela, Cuzzocrea, Salvatore, Arnatt, Christopher K., Spiegel, Sarah, Farr, Susan A., Salvemini, Daniela
Publicado 2022

Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain

por Stockstill, Katherine, Doyle, Timothy M., Yan, Xisheng, Chen, Zhoumou, Janes, Kali, Little, Joshua W., Braden, Kathryn, Lauro, Filomena, Giancotti, Luigino Antonio, Harada, Caron Mitsue, Yadav, Ruchi, Xiao, Wen Hua, Lionberger, Jack M., Neumann, William L., Bennett, Gary J., Weng, Han-Rong, Spiegel, Sarah, Salvemini, Daniela
Publicado 2018